rfXcel - Safety through Traceability™
Events Press Releases Media Resources
Request more information
Press Releases
October 08, 2009
rfXcel and Activant Solutions Inc. Announce a Partnership for Drug Pedigree and Traceability
Partnership Provides an Integrated Solution for Complete Supply Chain Traceability
YARDLEY, PA, October 08, 2009 - rfXcel Corporation, the leading provider of production-proven ePedigree and Track and Trace Systems, today announced it has signed an agreement to partner with Activant Solutions Inc., a leading technology provider of business management solutions. This partnership will provide Activant® customers with the ability to trace pharmaceuticals and ingredients from origin to destination, enabling a quick and less costly response to supply chain incidents and recalls and providing compliance with government regulations.
“Our partnership with rfXcel will give our medical supply customers traceability and Pedigree capabilities,“ said Kevin Roach, executive vice president and general manager of Activant, a leading technology provider to medical distributors. ”This powerful combination of the Activant Distribution Suite™ and rfXcel’s pedigree and traceability solutions will provide a much-needed ability to trace products in the supply chain and produce government compliant pedigrees as well as respond quickly and accurately to any problems encountered there.”
Jack Tarkoff, vice president of sales at rfXcel, commented, “We’re pleased that our partnership with Activant will create a great opportunity to easily provide a solution for product pedigree and traceability to Activant’s customers. Activant’s comprehensive suite of enterprise software provides the perfect foundation for rfxcel’s industry-proven pedigree tracking solution.”
Integration of rfXcel’s pedigree and traceability systems with Activant’s Prophet 21® system is through a direct interface, enabling Activant customers to access to rfXcel products, including the Active ePedigree Management™ System and the Raw Materials, Ingredients & Finished Goods Traceability products. Pedigree tracking is a Food & Drug Administration (FDA) and State requirement that compels pharmaceutical manufacturers, wholesalers, and retailers to track drugs throughout the supply chain. rfXcel’s Traceability solution provides customers with the ability to trace both internal and external transactions and provide complete traceability from the origin of the raw materials or ingredients, through the manufacturing of the finished goods, all the way to the retailer or dispenser in one system.
About rfXcel Corporation
rfXcel, founded in 2003, is headquartered in San Ramon, CA. rfXcel is a pioneer in creating real-time supply-chain performance improvement and compliance applications for retailers, manufacturers and distributors. rfXcel solutions can be implemented today, yet have the capability to scale as infrastructure technology develops. The rfXcel management team and board are comprised of industry experts that come directly from the life sciences, technology and consumer goods industries. rfXcel was founded on the principle of providing real business value to our customers by developing solutions that solve supply chain problems that they face every business day. More information on the Company can be found at: www.rfxcel.com
About Activant Solutions Inc.
Activant Solutions Inc. (“Activant”) is a leading technology provider of business management solutions serving retail and wholesale distribution businesses in three primary vertical markets: hardlines and lumber; wholesale distribution; and the automotive parts aftermarket. Founded in 1972, Activant provides customers with tailored proprietary software, professional services, content, supply chain connectivity, and analytics. More than 30,000 customer locations use an Activant solution to manage their day-to-day operations. Activant has operations throughout the United States and Canada, Ireland, and the United Kingdom.
For more information, please visit distribution.epicor.com.
This announcement relating to Activant may contain statements that are forward looking within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, such as statements concerning trends, future technology or products, or Activant’s execution. These statements are based on current expectations and are subject to risks and uncertainties which could materially affect the company’s results, including, without limitation, market demand for products and technology, the company’s ability to meet that market demand, the integration of Activant’s technology and products with technology and products supplied by others, the integration of Activant’s products into the businesses of its customers, customer acceptance of Activant’s products, and the retention and deployment of skilled Activant service providers. Except to the extent required by applicable securities laws, we undertake no obligation to update or publicly revise any of the forward-looking statements. Please refer to our Annual Report on Form 10-K for the period ended September 30, 2008 and our most recently filed Quarterly Report on Form 10-Q for the period ended March 31, 2009, which have been filed with the Securities Exchange Commission and can be found through the Activant investor relations website at www.activant.com/company/investors for a full discussion of the risks and other factors.
© 2009, Activant Solutions Inc. All rights reserved. Activant, the Activant logo, and Prophet 21 are registered trademarks, and Activant Distribution Suite is a trademark, of Activant Solutions Inc. All other trademarks are the property of their respective owners.